Browse history interactively

Page 1

Page 1Revision 1

Page 2

Page 2Revision 2

← Previous editContent deleted Content addedVisualWikitext

Revision as of 11:49, 9 August 2011 editBeetstra (talk | contribs)Edit filter managers, Administrators172,031 edits Script assisted update of identifiers for the Chem/Drugbox validation project (updated: 'UNII').← Previous edit		Latest revision as of 14:35, 22 September 2024 edit undo2406:3003:2004:64fa:f95d:b367:674:c2f (talk) Corrected WP linkTag: Visual edit
(73 intermediate revisions by 48 users not shown)
Line 1:		Line 1:
			{{Short description|Chemical compound}}
⚫	{{Drugbox| verifiedrevid = 415527556
			{{cs1 config |name-list-style=vanc |display-authors=6}}
	|used in strepsils
			{{Drugbox
⚫	|IUPAC_name = 4-hexylbenzene-1,3-diol
		⚫	| verifiedrevid = 443857623
⚫	| image=Hexylresorcinol.svg
		⚫	| IUPAC_name = 4-hexylbenzene-1,3-diol
⚫	| image2=Hexylresorcinol-3D-balls.png
		⚫	| image = 4-Hexylresorcinol.svg
		⚫	| image2 = 4-Hexylresorcinol-3D-balls.png
			<!--Clinical data-->
			| tradename = S.T.37, Crystoids<ref>{{cite web |title=Hexylresorcinol |url=https://webbook.nist.gov/cgi/cbook.cgi?ID=136-77-6 |website=NIST Chemistry WebBook, SRD 69 |publisher=NIST |access-date=19 April 2024}}</ref>
			| Drugs.com = {{drugs.com|international|hexylresorcinol}}
		⚫	| pregnancy_category =
		⚫	| legal_status =
		⚫	| routes_of_administration =
			<!--Pharmacokinetic data-->
		⚫	| bioavailability =
		⚫	| metabolism =
		⚫	| excretion =
			<!--Identifiers-->
			| CAS_number_Ref = {{cascite|correct|??}}
		⚫	| CAS_number = 136-77-6
		⚫	| ATC_prefix = R02
		⚫	| ATC_suffix = AA12
		⚫	| PubChem = 3610
			| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
		⚫	| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
		⚫	| ChemSpiderID = 21106121
			| UNII_Ref = {{fdacite|correct|FDA}}
		⚫	| UNII = R9QTB5E82N
	| KEGG_Ref = {{keggcite|correct|kegg}}		| KEGG_Ref = {{keggcite|correct|kegg}}
	| KEGG = D04441		| KEGG = D04441
	| InChI = 1/C12H18O2/c1-2-3-4-5-6-10-7-8-11(13)9-12(10)14/h7-9,13-14H,2-6H2,1H3
	| InChIKey = WFJIVOKAWHGMBH-UHFFFAOYAH
⚫	| smiles = Oc1cc(O)ccc1CCCCCC
	| ChEMBL_Ref = {{ebicite|correct|EBI}}		| ChEMBL_Ref = {{ebicite|correct|EBI}}
	| ChEMBL = 443605		| ChEMBL = 443605
			<!--Chemical data-->
		⚫	| C=12 | H=18 | O=2
			| melting_point = 68
			| melting_high = 69
			| boiling_point = 333
			| boiling_high = 335
		⚫	| smiles = Oc1cc(O)ccc1CCCCCC
	| StdInChI_Ref = {{stdinchicite|correct|chemspider}}		| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
	| StdInChI = 1S/C12H18O2/c1-2-3-4-5-6-10-7-8-11(13)9-12(10)14/h7-9,13-14H,2-6H2,1H3		| StdInChI = 1S/C12H18O2/c1-2-3-4-5-6-10-7-8-11(13)9-12(10)14/h7-9,13-14H,2-6H2,1H3
	| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}		| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
	| StdInChIKey = WFJIVOKAWHGMBH-UHFFFAOYSA-N		| StdInChIKey = WFJIVOKAWHGMBH-UHFFFAOYSA-N
⚫	| CAS_number=136-77-6
⚫	| ATC_prefix=R02
⚫	| ATC_suffix=AA12
	| ATC_supplemental=
⚫	| UNII = R9QTB5E82N
⚫	| PubChem=3610
⚫	| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
⚫	| ChemSpiderID=21106121
	| DrugBank=
⚫	| C=12 | H=18 | O=2
	| molecular_weight = 194.27
⚫	| bioavailability=
⚫	| metabolism =
	| elimination_half-life=
⚫	| excretion =
⚫	| pregnancy_category =
⚫	| legal_status =
⚫	| routes_of_administration=
	}}		}}
	'''Hexylresorcinol''' is a chemical compound with ], ] and ] properties.
			'''4-Hexylresorcinol''' is an ] with ], ], and ] properties.<ref>{{cite book | vauthors = Gisvold O | year = 1966 | title = Textbook of Organic Medicinal and Pharmaceutical Chemistry | edition = 5th | veditors = Wilson CO, Gisvold O, Doerge RF | pages = 237–262 | location = Philadelphia | publisher = Lippincott}}</ref>
	It can be used topically on small ]s, or as an ingredient in ]s.
			As an ], it is marketed as '''S.T.37''' by Numark Laboratories, Inc. (in a 0.1% solution) for oral pain relief and as a topical antiseptic. It is available for use topically on small ]s or as an ingredient in ]s.
	An ingredient in ] Extra (but not Strepsils Original) and, as a 0,1% solution, it is the active ingredient in S.T.37, Topical Antiseptic/Oral Pain Reliever.
			As an ], 4-hexylresorcinol was sold under the brand Crystoids.<ref>{{cite web |title=Anthelmintic Crystoids |url=https://americanhistory.si.edu/collections/nmah_212530 |publisher=National Museum of American History |access-date=19 April 2024 | id = ID number 1985.0481.142 |format=Object in collection}}</ref>
	A study published in Chemical Research in Toxicology in March 2009<ref>Chem. Res. Toxicol., 2009, 22 (1), pp 52–63</ref> shows that 4-hexylresorcinol used as a food additive (E-586) exhibits some estrogenic activity, i.e. resembles action of the female sex hormone ].
			Sytheon Ltd., USA markets 4-hexylresorcinol (trade named Synovea HR).
			] uses 4-hexylresorcinol in its ], Aveno, and RoC skincare products as an ]. 4-Hexylresorcinol has been used commercially by many cosmetic and personal care companies, such as ], ], ], ], ], ], and many small and large companies.
			A study published in '']'' <ref>{{cite journal | vauthors = Amadasi A, Mozzarelli A, Meda C, Maggi A, Cozzini P | title = Identification of xenoestrogens in food additives by an integrated in silico and in vitro approach | journal = Chemical Research in Toxicology | volume = 22 | issue = 1 | pages = 52–63 | date = January 2009 | pmid = 19063592 | pmc = 2758355 | doi = 10.1021/tx800048m }}</ref> shows that 4-hexylresorcinol used as a ] (E-586) exhibits some estrogenic activity, i.e. resembles action of the female sex hormone ]. However, a recent study published in '']'' <ref name=":0">{{cite journal | vauthors = Kang YJ, Oh JH, Seok H, Jo YY, Kim DW, Garagiola U, Choi JY, Kim SG | journal = Applied Sciences| year = 2020 | volume = 10 | issue = 5 | pages = 1737 | doi = 10.3390/app10051737 | title = 4-Hexylresorcinol Exhibits Different Characteristics to Estrogen| doi-access = free | hdl = 2434/962276 | hdl-access = free }}</ref> shows that 4-hexylresorcinol did not change the expression of estrogen receptor-α, -β, or p-ERK1/2 in MCF-7 cells. In an ovariectomized animal model, the 4HR group showed similar levels of ERα, ERβ, and prolactin expression in the pituitary gland compared to the solvent only group, while the estradiol group showed higher levels. Serum prolactin levels were similar between the 4HR and solvent only groups.<ref name=":0" />
			In one study, 4-hexylresorcinol increased the ] of ] by reducing ] (black spots).<ref>{{cite journal | journal=Journal of Food Science | year=2006 | vauthors = Montero P | title=Effectiveness of Onboard Application of 4-Hexylresorcinol in Inhibiting Melanosis in Shrimp (''{{Interlanguage link multi|Parapenaeus longirostris|es}}'') | doi=10.1111/j.1365-2621.2004.tb09913.x | volume=69 | pages=C643–C647}}</ref>
			In mice with cancer, 4-hexylresorcinol inhibited ] and extended their survival rate.<ref>{{cite journal | vauthors = Kim SG, Lee SW, Park YW, Jeong JH, Choi JY | title = 4-hexylresorcinol inhibits NF-κB phosphorylation and has a synergistic effect with cisplatin in KB cells | journal = Oncology Reports | volume = 26 | issue = 6 | pages = 1527–32 | date = December 2011 | pmid = 21874263 | doi = 10.3892/or.2011.1436 | doi-access = free }}</ref>
			4-Hexylresorcinol can be used in the synthesis of ]<ref>{{cite journal | doi = 10.1021/ja01255a061 | title = Tetrahydrocannabinol Homologs and Analogs with Marihuana Activity. XIII<sup>1</sup> | date = 1942 | vauthors = Adams R, Loewe S, Smith CM, McPhee WD | journal = Journal of the American Chemical Society | volume = 64 | issue = 3 | pages = 694–697 }}</ref>
	== References ==		== References ==
			{{Reflist}}
	<references />
	{{Throat preparations}}		{{Throat preparations}}
			{{Anthelmintics}}
⚫	]
		⚫	{{DEFAULTSORT:hexylresorcinol}}
	]		]
	]		]
	]		]
	]		]
			]
		⚫	]
	{{respiratory-system-drug-stub}}
	{{nervous-system-drug-stub}}
	]
⚫	]
	]